ClearBridge Investments’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $200M | Buy |
379,502
+71,025
| +23% | +$39.8M | 0.17% | 145 |
|
|
2026
Q1 | $173M | Buy |
308,477
+15,529
| +5% | +$9.96M | 0.15% | 144 |
|
|
2025
Q4 | $198M | Buy |
292,948
+12,101
| +4% | +$8.24M | 0.16% | 137 |
|
|
2025
Q3 | $179M | Sell |
280,847
-2,918
| -1% | -$1.77M | 0.14% | 161 |
|
|
2025
Q2 | $152M | Sell |
283,765
-53,292
| -16% | -$25.5M | 0.12% | 162 |
|
|
2025
Q1 | $142M | Buy |
337,057
+84,929
| +34% | +$36.9M | 0.12% | 172 |
|
|
2024
Q4 | $104M | Sell |
252,128
-90,976
| -27% | -$39.9M | 0.08% | 225 |
|
|
2024
Q3 | $173M | Sell |
343,104
-9,710
| -3% | -$4.72M | 0.14% | 152 |
|
|
2024
Q2 | $172M | Buy |
352,814
+308,493
| +696% | +$155M | 0.14% | 153 |
|
|
2024
Q1 | $23.9M | Buy |
44,321
+1,479
| +3% | +$808K | 0.02% | 436 |
|
|
2023
Q4 | $23.8M | Buy |
42,842
+405
| +1% | +$190K | 0.02% | 444 |
|
|
2023
Q3 | $18.6M | Buy |
42,437
+388
| +0.9% | +$193K | 0.02% | 437 |
|
|
2023
Q2 | $21.1M | Buy |
42,049
+1,319
| +3% | +$632K | 0.02% | 433 |
|
|
2023
Q1 | $20.4M | Buy |
40,730
+31,965
| +365% | +$15.3M | 0.02% | 426 |
|
|
2022
Q4 | $3.58M | Buy |
8,765
+369
| +4% | +$143K | ﹤0.01% | 587 |
|
|
2022
Q3 | $2.73M | Buy |
8,396
+501
| +6% | +$184K | ﹤0.01% | 608 |
|
|
2022
Q2 | $2.77M | Sell |
7,895
-511
| -6% | -$208K | ﹤0.01% | 616 |
|
|
2022
Q1 | $4.6M | Sell |
8,406
-7
| -0.1% | -$3.68K | ﹤0.01% | 608 |
|
|
2021
Q4 | $5.54M | Buy |
8,413
+625
| +8% | +$392K | ﹤0.01% | 607 |
|
|
2021
Q3 | $4.84M | Buy |
7,788
+1,106
| +17% | +$743K | ﹤0.01% | 620 |
|
|
2021
Q2 | $4.22M | Buy |
6,682
+81
| +1% | +$44.7K | ﹤0.01% | 626 |
|
|
2021
Q1 | $3.23M | Buy |
6,601
+8
| +0.1% | +$4.01K | ﹤0.01% | 621 |
|
|
2020
Q4 | $3.3M | Sell |
6,593
-114
| -2% | -$51K | ﹤0.01% | 608 |
|
|
2020
Q3 | $2.64M | Sell |
6,707
-143
| -2% | -$52.9K | ﹤0.01% | 608 |
|
|
2020
Q2 | $2.26M | Sell |
6,850
-107,309
| -94% | -$31.1M | ﹤0.01% | 593 |
|
|
2020
Q1 | $27.7M | Sell |
114,159
-1,061
| -0.9% | -$277K | 0.03% | 326 |
|
|
2019
Q4 | $30.5M | Buy |
115,220
+1,532
| +1% | +$404K | 0.03% | 383 |
|
|
2019
Q3 | $30.9M | Buy |
113,688
+1,700
| +2% | +$473K | 0.03% | 375 |
|
|
2019
Q2 | $30.8M | Buy |
111,988
+6,375
| +6% | +$1.57M | 0.03% | 371 |
|
|
2019
Q1 | $23.6M | Buy |
105,613
+3,858
| +4% | +$796K | 0.02% | 404 |
|
|
2018
Q4 | $18.9M | Buy |
101,755
+32,076
| +46% | +$6.58M | 0.02% | 423 |
|
|
2018
Q3 | $17.4M | Sell |
69,679
-112
| -0.2% | -$27.2K | 0.02% | 460 |
|
|
2018
Q2 | $15.2M | Buy |
69,791
+4,620
| +7% | +$952K | 0.01% | 435 |
|
|
2018
Q1 | $12.5M | Buy |
65,171
+1,720
| +3% | +$317K | 0.01% | 449 |
|
|
2017
Q4 | $9.92M | Buy |
+63,451
| New | +$9.99M | 0.01% | 480 |
|
Other funds holding IDXX
VCM
VPM
ClearBridge Investments's IDXX Position: Q2 2026 in Review
ClearBridge Investments increased its Idexx Laboratories (IDXX) stake by 23% in Q2 2026, buying an estimated $39.8M and bringing the position to 379,502 shares worth $200M. The position accounts for 0.17% of the portfolio, ranked #145.
ClearBridge Investments first reported a position in IDXX in Q4 2017 and has held it in 35 quarters since. 1,051 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- ClearBridge Investments held 379,502 shares of Idexx Laboratories worth $200M as of Q2 2026.
- ClearBridge Investments bought 71,025 Idexx Laboratories shares in Q2 2026, an estimated $39.8M.
- Idexx Laboratories made up 0.17% of ClearBridge Investments's portfolio in Q2 2026, its #145 holding.
- ClearBridge Investments first reported a position in Idexx Laboratories in Q4 2017 and has held it in 35 quarters since.
- 1,051 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on ClearBridge Investments's 13F filing for Q2 2026, filed 13 Aug 2026.